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Interview with SKMC student David Hoang:
The academic path that sparked a journey beyond the walls of clinical care
Describe your academic
background.
I actually started at Jefferson in 2008 and
did the combined degree program, which
is an 8-year program. I did the first two
years, the preclinical years in the medical
school, and then I started my PhD in
Biochemistry. I did four years of research
and then did my thesis defense in August
of 2014 when I basically completed all
the requirements for the PhD degree. My
specific area of research was in prostate
cancer biology with Dr. Marja Navalainen,
who was with the Kimmel Cancer Center
at the time. After finishing my research, I
returned to medical school to finish the
last two clinical years.
I’ve always been the kind of person that
likes to impact health care from a larger
perspective. I realized that the day in
and day out of being a clinician is very
rewarding, but the impact there is less
then what you might get through larger
avenues, such as research or development
of a drug or a therapy that may potentially
reach a larger population. That’s what
really drove me to go that route.

What motivated you to enroll
in the elective, “Business of
Medicine” at Weill Cornell
Medicine?
While working on my PhD, I was fortunate
to connect with a few alumni of Jefferson
who had migrated over to industry and I
found their perspectives pretty interesting.
I wanted more exposure to that; this
internship was an opportunity to get that
exposure in a condensed timeframe.
This internship was part of a 2-month

course. Through a professor at Weill
Cornell, I was connected to Huron
Consulting Group. They have practices in
healthcare as well as life sciences. I was
in the life sciences practice and my job
consisted of day to day interacting with a
number of clients in the pharmaceutical
and biotech industry. The length of the
internship was the same length of the
course.

What did you work on at Huron?
One of the projects was in lung cancer,
and I got exposed to the cutting edge of
what is going on right now in the field
in terms of therapies. Part of my job was
to try to predict where the field is going
within the next 10 years, which was really
fascinating to me. I had to take the current
knowledge and extrapolate out to the
future treatment paradigms. That kind of
work was very intellectual and pulled on
both research and clinical skills.
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experience. I realized how many people
actually have to get mobilized to move a
new idea forward, launch a new product, or
change direction.

How do you think you will use
this experience in your career?

I really enjoyed the people at Huron,
they were fantastic, and it was an
interdisciplinary environment. People
came from many different backgrounds,
and the majority did have a business
background of some sort.

In the short-term, I do have an opportunity
as soon as I graduate in June with another
company, doing similar work that I did
at Huron. In the future, I would like to
be in a senior leadership position at a
pharmaceutical or biotech company.

What did you learn that you didn’t
anticipate learning?

Would you encourage other MD
students to participate in similar
courses and internships?

I learned how a business or large
organization functioned. This for me was
a step in a totally new direction. I’m used
to being in the trenches. But there was an
organizational aspect, and part of that was
learning how to communicate with people
at all different levels – from the board
down through different departments and
operational levels. That to me was a new

Yes, any medical student that has any
type of interest in anything outside of
direct clinical practice could benefit from
something like this. I think there’s a lot of
flexibility in these types of opportunities
in terms of getting the type of experience
desired by the student.
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As you embark on this new
journey, what are some of your
reflections on your time at
Jefferson and your career path?
This hasn’t been the most direct pathway.
I enjoyed my time at Jefferson a great
deal in all the different facets that I’ve
experienced. Many times your career path
doesn’t unfold linearly, and there’s nothing

wrong with that. Sometimes students are
anxious about having everything lined up,
but my advice to younger students is that
you don’t necessarily need to have that in
place. Sometimes the best way to go is to
let it unfold naturally.
Looking at the past eight years, I really
like this new direction Jefferson is going.
There has been a true interdisciplinary
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push and I think Dr. Klasko has done a lot
to move it in that direction. I see many
efforts to connect between different
departments, and implement new
initiatives, and realize as an organization,
that we all are involved in the mission of
improving health and to get there we need
to truly work as a team.
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